MedTrace Logo

Function of Circulating Exosomes in Sepsis-induced Immunosuppression

NCT04979767 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-07-28

No results posted yet for this study

Summary

This is a single-center prospective bio-specimen analysis and observational study aiming to define immune pathways disrupted in bacterial sepsis and to identify clinically useful biomarkers of immune status.

Conditions

  • Sepsis
  • Septic Shock
  • Sepsis Syndrome
  • Sepsis Bacterial
  • Sepsis, Severe
  • Sepsis Bacteremia

Sponsors & Collaborators

  • University of Kansas

    collaborator OTHER

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Nicholas S Britt, PharmD · University of Kansas Medical Center

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2021-10-31
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04979767 on ClinicalTrials.gov